Management of variceal bleeding in the liver transplant waiting list
https://doi.org/10.15825/1995-1191-2020-4-58-64
Abstract
Objective: to study the outcomes of main surgical methods for stopping and preventing variceal hemorrhage in waitlisted cirrhotic patients.
Material and methods. In our prospective case-control study, the «case» cohort included 132 patients with cirrhosis complicated by recurrent varicose bleeding, while the «control» group consisted of 92 patients with one episode of bleeding esophageal varices. Treatment included conservative therapy, endoscopic ligation, transjugular intrahepatic portosystemic shunt, and the original azygoportal disconnection technique.
Results. High MELD scores, severe hepatic encephalopathy, portal vein thrombosis, high degree of varices, and recurrent bleeding significantly affect the mortality of cirrhotic patients. Irrational use of nonselective beta-blocker monotherapy has a negative impact on treatment outcomes. Combined use of drug therapy and surgical methods of stopping and preventing varicose bleeding, reduces the number of relapses, prolongs patients’ life to two years or more, which allows to move on to the next stage of cirrhosis treatment – liver transplantation.
Conclusion. The likelihood of recurrent variceal hemorrhage increases in patients who undergo passive surgical tactics. Azygoportal disconnection should be considered as the operation of choice if the patient has more than one episode of variceal bleeding. Timely and adequate treatment measures, clinical and diagnostic monitoring reduce waitlist mortality.
About the Authors
V. L. Korobka
Rostov Regional Clinical Hospital;
Rostov State Medical University
Russian Federation
Rostov-on-Don
Russian Federation
Rostov-on-Don
M. Yu. Kostrykin
Rostov Regional Clinical Hospital
Russian Federation
Russian Federation
170, Blagodatnaya str., Rostov-on-Don, 344015, Russian Federation
Phone: (918) 554-16-28
A. M. Shapovalov
Rostov Regional Clinical Hospital
Russian Federation
Rostov-on-Don
Russian Federation
Rostov-on-Don
References
1. Karatzas A, Konstantakis C, Aggeletopoulou I, Kalogeropoulou C, Thomopoulos K, Triantos C. Νon-invasive screening for esophageal varices in patients with liver cirrhosis. Ann Gastroenterol. 2018; 31 (3): 305–314. https://doi.org/10.20524/aog.2018.0241.
2. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol. 2020; 26 (2): 83–127. https://doi.org/10.3350/cmh.2019.0010n.
3. Biecker E. Gastrointestinal bleeding in cirrhotic patients with portal hypertension. ISRN Hepatol. 2013; 2013: 541836. Published 2013 Jul 22. https://doi.org/10.1155/2013/541836.
4. Mallet M, Rudler M, Thabut D. Variceal bleeding in cirrhotic patients. Gastroenterol Rep (Oxf). 2017; 5 (3): 185–192. doi: 10.1093/gastro/gox024.
5. Malomuzh OI, Kpel’ PE, Gautier SV, Tsipul’nikova OM et al. Prognosis for patients with chronic diseases of the liver in formulating indications to orthotopic liver transplantation. Terapevticheskii arkhiv. 2009; 81 (2): 45–49. (In Russ.).
6. Seo YS. Prevention and management of gastroesophageal varices. Clin Mol Hepatol. 2018; 24 (1): 20–42. https://doi.org/10.3350/cmh.2017.0064.
7. Boregowda U, Umapathy C, Halim N et al. Update on the management of gastrointestinal varices. World J Gastrointest Pharmacol Ther. 2019; 10 (1): 1–21. https://doi.org/10.4292/wjgpt.v10.i1.1.
8. Onnitsev IE, Bugaev SA, Ivanusa SYa et al. Prevention of recurrent bleeding from varicose veins of the esophagus and stomach among patients with decompensated liver cirrhosis. Kazan medical journal. 2019; 100 (2): 333–339. (In Russ.). https://doi.org/10.17816/KMJ2019-333.
9. Zanetto A, Garcia-Tsao G. Management of acute variceal hemorrhage. F1000Res. 2019; 8: F1000 Faculty Rev-966. Published 2019 Jun 25. https://doi.org/10.12688/f1000research.18807.1.
10. Yang L, Yuan LJ, Dong R et al. Two surgical procedures for esophagogastric variceal bleeding in patients with portal hypertension. World J Gastroenterol. 2013; 19 (48): 9418–9424. https://doi.org/10.3748/wjg.v19.i48.9418.
11. Coelho FF, Perini MV, Kruger JA et al. Management of variceal hemorrhage: current concepts. Arq Bras Cir Dig. 2014; 27 (2): 138–144. https://doi.org/10.1590/s0102-67202014000200011.
12. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016 Feb; 64 (2): 433–485. https://doi.org/10.1016/j.jhep.2015.10.006.
13. Toniutto P, Zanetto A, Ferrarese A et al. Current challenges and future directions for liver transplantation. Liver Int. 2017; 37 (3): 317–327. https://doi.org/10.1111/liv.13255.
14. Samuel D, Coilly A. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. BMC Med. 2018; 16 (1): 113. Published 2018 Aug 1. https://doi.org/10.1186/s12916-018-1110-y.
15. Korobka VL, Shapovalov AM, Danil’chuk OYa, Korobka RV. Sposob khirurgicheskogo lecheniya i profilaktiki retsidiva krovotecheniy pri varikoznom rasshirenii ven pishchevoda i kardial’nogo otdela zheludka. Patent na izobretenie RU 2412657 C1, 27.02.2011. Zayavka № 2009128518/14 ot 23.07.2009.
Review
For citations:
Korobka V.L., Kostrykin M.Yu., Shapovalov A.M. Management of variceal bleeding in the liver transplant waiting list. Russian Journal of Transplantology and Artificial Organs. 2020;22(4):58-64. https://doi.org/10.15825/1995-1191-2020-4-58-64
Views:
822
Email this article 